Page last updated: 2024-08-26

lysophosphatidic acid and Osteosarcoma

lysophosphatidic acid has been researched along with Osteosarcoma in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Kondo, D; Kurisu, R; Minami, K; Otani, T; Sakai, Y; Shima, N; Takamoto, M; Tsujiuchi, T; Ueda, N; Yamada, M1
Ikeda, H; Ishimoto, K; Kurisu, R; Minami, K; Takamoto, M; Tsujiuchi, T; Ueda, N1
Ae, K; Fujita, N; Funauchi, Y; Haraguchi, M; Katayama, R; Kawaguchi, T; Koike, S; Matsumoto, S; Saito, M; Sasaki, Y; Seto, Y; Sugawara, M; Takagi, S; Takemoto, A; Ukaji, T1
Homma, Y; Kikuchi, H; Komachi, M; Kubohara, Y; Oshima, Y1
Devaney, T; Huber, E; Kitz, K; Leis, HJ; Malle, E; Rauh, A; Rossmann, C; Semlitsch, M; Windischhofer, W1
Checovich, WJ; Mosher, DF1

Other Studies

6 other study(ies) available for lysophosphatidic acid and Osteosarcoma

ArticleYear
Effects of lysophosphatidic acid (LPA) signaling via LPA receptors on cellular functions associated with ATP reduction in osteosarcoma cells treated with ethidium bromide.
    Journal of bioenergetics and biomembranes, 2022, Volume: 54, Issue:2

    Topics: Adenosine Triphosphate; Bone Neoplasms; Cell Movement; Ethidium; Gene Expression Regulation, Neoplastic; Humans; Lysophospholipids; Osteosarcoma; Receptors, Lysophosphatidic Acid

2022
Roles of endothelial cells in the regulation of cell motility via lysophosphatidic acid receptor-2 (LPA
    Experimental and molecular pathology, 2021, Volume: 118

    Topics: Apoptosis; Bone Neoplasms; Cell Movement; Cell Proliferation; Endothelial Cells; Gene Expression Regulation, Neoplastic; Humans; Lysophospholipids; Osteosarcoma; Receptors, Lysophosphatidic Acid; Signal Transduction; Tumor Cells, Cultured

2021
Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasis.
    Oncogene, 2021, Volume: 40, Issue:36

    Topics: Blood Platelets; Humans; Lung Neoplasms; Lysophospholipids; Osteosarcoma; Transcriptional Activation

2021
Derivatives of Dictyostelium differentiation-inducing factors inhibit lysophosphatidic acid-stimulated migration of murine osteosarcoma LM8 cells.
    Biochemical and biophysical research communications, 2015, Aug-07, Volume: 463, Issue:4

    Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dictyostelium; Hexanones; Lysophospholipids; Mice; Mitochondria; Osteosarcoma; Oxygen Consumption; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction

2015
LPA-induced suppression of periostin in human osteosarcoma cells is mediated by the LPA(1)/Egr-1 axis.
    Biochimie, 2012, Volume: 94, Issue:9

    Topics: Cell Adhesion Molecules; Cell Line, Tumor; Cell Proliferation; DNA; Early Growth Response Protein 1; Gene Expression Regulation, Neoplastic; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Lysophospholipids; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Osteosarcoma; Receptors, Lysophosphatidic Acid; RNA, Messenger

2012
Lysophosphatidic acid enhances fibronectin binding to adherent cells.
    Arteriosclerosis and thrombosis : a journal of vascular biology, 1993, Volume: 13, Issue:11

    Topics: Binding Sites; Cell Adhesion; Cell Line, Transformed; Fibroblasts; Fibronectins; Humans; Lysophospholipase; Lysophospholipids; Male; Osteosarcoma; Peptide Fragments; Phosphatidic Acids; Phospholipases A; Tumor Cells, Cultured

1993